Gelonghui April 27?Guangji Pharmaceutical (000952.SZ) released a report for the first quarter of 2023, with operating income of 115 million yuan during the reporting period, down 13.49% from the same period last year; net profit belonging to shareholders of listed companies was-44.0385 million yuan; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was-44.9332 million yuan; basic earnings per share was-0.1244 yuan.
广济药业(000952.SZ)：一季度净亏损4403.85万元
Guangji Pharmaceutical (000952.SZ): Net loss of 44,038,500 yuan in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.